Application for this study are now closed
Browse our other trials that are currently recruiting
F00523 Recombinant Protein Influenza Vaccine
Fusion Norwood
A potential new influenza vaccine using recombinant protein vaccine technology compared with currently approved flu vaccines is currently being trialled at Fusion Norwood. You may be eligible to participate in this trial, register your interest or get in contact with us today!
Eligibility requirements
- Age: 18 - 60yrs
- Sex: M & F
- BMI: 19 - 40
- Medication: – Must be fully vaccinated with licensed COVID-19 vaccines – Must not have another influenza vaccine within 6 months prior to planned vaccination
Payment/Remuneration
- up to $450 if you complete all study requirements